DK174229B1 - Antibiotisk reuterin - Google Patents

Antibiotisk reuterin Download PDF

Info

Publication number
DK174229B1
DK174229B1 DK198905428A DK542889A DK174229B1 DK 174229 B1 DK174229 B1 DK 174229B1 DK 198905428 A DK198905428 A DK 198905428A DK 542889 A DK542889 A DK 542889A DK 174229 B1 DK174229 B1 DK 174229B1
Authority
DK
Denmark
Prior art keywords
reuterin
glycerol
reuteri
lactobacillus
agent
Prior art date
Application number
DK198905428A
Other languages
Danish (da)
English (en)
Other versions
DK542889D0 (da
DK542889A (da
Inventor
Walter J Dobrogosz
Sven E Lindgren
Original Assignee
Biogaia Biolog Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Biolog Ab filed Critical Biogaia Biolog Ab
Publication of DK542889D0 publication Critical patent/DK542889D0/da
Publication of DK542889A publication Critical patent/DK542889A/da
Application granted granted Critical
Publication of DK174229B1 publication Critical patent/DK174229B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198905428A 1987-05-01 1989-10-31 Antibiotisk reuterin DK174229B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4602787A 1987-05-01 1987-05-01
US4602787 1987-05-01
US10283087A 1987-09-22 1987-09-22
US10283087 1987-09-22
PCT/US1988/001423 WO1988008452A1 (fr) 1987-05-01 1988-04-28 Reuterine antibiotique
US8801423 1988-04-28

Publications (3)

Publication Number Publication Date
DK542889D0 DK542889D0 (da) 1989-10-31
DK542889A DK542889A (da) 1989-10-31
DK174229B1 true DK174229B1 (da) 2002-10-07

Family

ID=26723487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198905428A DK174229B1 (da) 1987-05-01 1989-10-31 Antibiotisk reuterin

Country Status (10)

Country Link
EP (2) EP0698347B1 (fr)
JP (2) JP3007092B2 (fr)
AT (2) ATE145243T1 (fr)
AU (1) AU620807B2 (fr)
CA (1) CA1314255C (fr)
DE (2) DE3856591D1 (fr)
DK (1) DK174229B1 (fr)
FI (2) FI895197A0 (fr)
NO (2) NO301430B1 (fr)
WO (1) WO1988008452A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198425A (en) * 1989-08-30 1993-03-30 Bio-Mega, Inc. Inhibitors of bacterial ribonucleotide reductase
ES2174829T3 (es) * 1991-01-28 2002-11-16 Biogaia Ab Metodo para administrar el microorganismo lactobacillus reuteri como alimentacion directa a un organismo avicola in ovo.
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
GB9803424D0 (en) * 1998-02-18 1998-04-15 Pfizer Ltd Performance enhancement
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
EP2158813A1 (fr) 2008-08-28 2010-03-03 Omya Development AG Stabilisation de préparations minérales aqueuses par reuterine
WO2010045367A1 (fr) * 2008-10-14 2010-04-22 Dr Pepper/Seven Up, Inc. Compositions consommables longue conservation contenant des éléments imitant les probiotiques et leurs procédés de préparation et d’utilisation
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
ES2611028T3 (es) * 2011-11-30 2017-05-04 Compagnie Gervais Danone Lactobacillus brevis productor de reuterina
CA2868288A1 (fr) 2012-04-16 2013-10-24 Cascades Canada Ulc Compositions antimicrobiennes renfermant de la pediocine, de l'acide lactique et de l'acide nitrique, et ses utilisations
JP2015520773A (ja) * 2012-05-29 2015-07-23 ダヌタ・クルセフスカＤａｎｕｔａＫＲＵＳＺＥＷＳＫＡ ヒトおよび動物における予防および医薬に有用であるラクトバチルス・ロイテリｄａｎ８０を含むナノ製品ならびにこれらの医薬用途
EP2674162A1 (fr) * 2012-05-29 2013-12-18 Danuta Kruszewska Nano-produit, comprenant des lactobacillus reuteri dan080, utile dans la prophylaxie, diagnostic et traitement médical et vétérinaire
CA2923982A1 (fr) 2013-08-12 2015-02-19 Mansel Griffiths Methodes et compositions antivirales comprenant des molecules bacteriennes probiotiques
ITUB20152987A1 (it) * 2015-08-07 2017-02-07 Minaba Tech S R L Procedimento di bio-conservazione di prodotti ittici e relativi prodotti
CN105340974B (zh) * 2015-10-30 2018-01-09 湖北省生物农药工程研究中心 一种生物拌种剂及应用
CN114806929B (zh) * 2022-03-29 2023-10-31 山东凤凰生物科技股份有限公司 一株高产罗伊氏菌素的罗伊氏乳杆菌lr4009及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687981A (en) * 1968-01-17 1972-08-29 Du Pont Process for making a dioxane
US4053638A (en) * 1970-05-06 1977-10-11 William Wrigley Jr. Company Anticaries confectioneries and oral health products
JPS60116369U (ja) 1984-01-11 1985-08-06 リョービ株式会社 ゴルフクラブメタルヘツド
US10283087B2 (en) 2016-06-15 2019-05-07 Sk Planet Co., Ltd. Digital signage device and method for operating the same

Also Published As

Publication number Publication date
NO963930D0 (no) 1996-09-19
NO885833L (no) 1989-02-28
DE3855664T2 (de) 1997-03-20
DK542889D0 (da) 1989-10-31
EP0357673A1 (fr) 1990-03-14
ATE332649T1 (de) 2006-08-15
JP3007092B2 (ja) 2000-02-07
FI960543A0 (fi) 1996-02-06
JPH11137292A (ja) 1999-05-25
JP3244659B2 (ja) 2002-01-07
FI895197A0 (fi) 1989-11-01
AU620807B2 (en) 1992-02-27
NO301430B1 (no) 1997-10-27
NO308982B1 (no) 2000-11-27
EP0698347A3 (fr) 1999-09-08
FI960543A (fi) 1996-02-06
EP0698347B1 (fr) 2006-07-12
CA1314255C (fr) 1993-03-09
EP0357673A4 (en) 1991-09-25
JPH02503385A (ja) 1990-10-18
NO885833D0 (no) 1988-12-30
DK542889A (da) 1989-10-31
DE3856591D1 (de) 2006-08-24
FI110366B (fi) 2002-12-31
AU1724588A (en) 1988-12-02
ATE145243T1 (de) 1996-11-15
WO1988008452A1 (fr) 1988-11-03
NO963930L (no) 1989-02-28
DE3855664D1 (de) 1996-12-19
EP0698347A2 (fr) 1996-02-28
EP0357673B1 (fr) 1996-11-13

Similar Documents

Publication Publication Date Title
DK174229B1 (da) Antibiotisk reuterin
US5849289A (en) Method for inhibiting microorganism growth
Chung et al. In vitro studies on reuterin synthesis by Lactobacillus reuteri
He et al. Microbial transformation of deoxynivalenol (vomitoxin)
Shima et al. Novel detoxification of the trichothecene mycotoxin deoxynivalenol by a soil bacterium isolated by enrichment culture
Ultee et al. Influence of carvacrol on growth and toxin production by Bacillus cereus
US5352586A (en) Method of determining the presence of an antibiotic produced by Lactobacillus reuteri
Nadathur et al. Antimutagenicity of fermented milk
Ndagijimana et al. Two 2 [5H]-furanones as possible signaling molecules in Lactobacillus helveticus
Al-Sahlany et al. Bacterial viability, antioxidant stability, antimutagenicity and sensory properties of onion types fermentation by using probiotic starter during storage
Gao et al. Screening of lactic acid bacteria with cholesterol-lowering and triglyceride-lowering activity in vitro and evaluation of probiotic function
EP1154692B1 (fr) Procede de lutte contre les pathogenes fongiques et agents utilises dans ce procede
Hinton Jr et al. In vitro inhibition of Salmonella typhimurium and Escherichia coli 0157: H7 by an anaerobic gram-positive coccus isolated from the cecal contents of adult chickens
Osawa et al. Metabolism of tannin-protein complex by facultatively anaerobic bacteria isolated from koala feces
KR101697535B1 (ko) 복분자로부터 분리한 락토바실러스 플란타룸 균주 및 이를 포함하는 식품 조성물
KR100769299B1 (ko) 알코올 분해능이 있는 유산균 및 그를 함유하는 유제품, 건강 기능성 식품 및 식품 첨가제
Rolin et al. 13 C-NMR study of lactate metabolism in Propionibacterium freudenreichii subsp. shermanii
Osman Factors affecting the antifungal properties of Brevibacterium linens
CA2493872C (fr) Accelerateur pour l'elimination des dioxines
Kole et al. Bovine bile resistance increases Leuconostoc oenos 44.40 viability upon lyophilization
Begunova et al. Optimization of Cultivation Conditions for the Lactobacillus reuteri LR1 Strain to Improve the Biosynthesis of Bacteriocin-Like Substances
Huang et al. Isolation, Identification and Characterization of α-cembratriene-4, 6-diol Degrading Stenotrophomonas maltophilia H3-1 and Optimized Its Growth Parameters
Marinkova et al. Antimicrobial activity of Bulgarian products and their extracts containing bioactive components
CN117598439A (zh) 一种用于生产泡椒凤爪以及提高其货架期的方法
Mihoub et al. Effects of garlic extract on cell wall of Corynebacterium glutamicum

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired